Dowding C, Th'ng K H, Goldman J M, Galton D A
Exp Hematol. 1984 Nov;12(10):811-15.
We measured the numbers of B- and T-lymphocytes in the peripheral blood of 40 patients with chronic granulocytic leukemia (CGL) at different stages in the chronic or stable phase of the disease. In untreated patients and in treated patients with relatively high leukocyte counts, T-cell numbers were increased: in the majority of cases this increase involved both "helper" (OKT4+) and "suppressor" (OKT8+) cells. B-cell numbers were normal. Patients whose leukocyte counts had been restored to normal by treatment with cytotoxic drugs had normal T-cell numbers, but B-cell numbers were reduced in comparison with normal persons. We conclude that untreated CGL is usually associated with a T-cell lymphocytosis that can be reversed by chemotherapy. The excess of T-lymphocytes in the blood before treatment is probably an immunological response to the neoplastic proliferation, but the possibility that some T-lymphocytes might be involved in the malignant clone cannot be excluded.
我们检测了40例处于慢性粒细胞白血病(CGL)慢性或稳定期不同阶段患者外周血中的B淋巴细胞和T淋巴细胞数量。在未治疗的患者以及白细胞计数相对较高的已治疗患者中,T细胞数量增加:在大多数情况下,这种增加涉及“辅助性”(OKT4 +)和“抑制性”(OKT8 +)细胞。B细胞数量正常。经细胞毒性药物治疗使白细胞计数恢复正常的患者,其T细胞数量正常,但与正常人相比,B细胞数量减少。我们得出结论,未经治疗的CGL通常与T细胞淋巴细胞增多症相关,化疗可使其逆转。治疗前血液中T淋巴细胞过多可能是对肿瘤增殖的免疫反应,但不能排除某些T淋巴细胞可能参与恶性克隆的可能性。